Cannabis Bioscience International Holdings, Inc. (CBIH): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$329.6K
Year ended 2025-05-31
-$268.1K
Trailing 12 months to 2026-02-28
2023-05-31: -$898.4K2024-05-31: -$479.4K2025-05-31: -$329.6K-$329.6K
2023-05-31 Operating Cash Flow (USD) 2025-05-31
Period endedOperating Cash FlowChange YoYSource filing
2025-05-31-$329.6Kn/m2025-09-22, From 2024-06-01
2024-05-31-$479.4Kn/m2025-09-22, From 2023-06-01
2023-05-31-$898.4Kn/a2024-09-16, From 2022-06-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31-$329.6Kn/m
OneMedNet Corp (ONMD)2025-12-31-$7.50Mn/m
iSpecimen Inc. (ISPC)2025-12-31-$4.24Mn/m
Absci Corp (ABSI)2025-12-31-$92.92Mn/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$9.33Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$3.87Mn/m
OmniAb, Inc. (OABI)2025-12-31-$36.45Mn/m
MaxCyte, Inc. (MXCT)2025-12-31-$34.41Mn/m
NRC Health (NRC)2025-12-31$26.45M-23.6%

Compare CBIH, ONMD, ISPC, ABSI side by side · Screen every company in Services-Commercial Physical & Biological Research ↗